XLV
XLV 2-star rating from Upturn Advisory

Health Care Select Sector SPDR® Fund (XLV)

Health Care Select Sector SPDR® Fund (XLV) 2-star rating from Upturn Advisory
$156.1
Last Close (24-hour delay)
Profit since last BUY15.13%
upturn advisory logo
Consider higher Upturn Star rating
BUY since 79 days
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/15/2025: XLV (2-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

Upturn 2 star rating for performance

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type ETF
Historic Profit 18.2%
Avg. Invested days 66
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
ETF Returns Performance Upturn Returns Performance icon 3.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/15/2025

Key Highlights

Volume (30-day avg) -
Beta 0.57
52 Weeks Range 126.75 - 156.97
Updated Date 06/29/2025
52 Weeks Range 126.75 - 156.97
Updated Date 06/29/2025

About Health Care Select Sector SPDR® Fund

Exchange NYSE ARCA
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.